Effects of GLP-1 Agonists on mortality and arrhythmias in patients with Type II diabetes

BACKGROUND: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) are frequently used for the management of diabetes. The impact of GLP-1 RA on cardiovascular outcomes is unclear. We aim to assess the effect of GLP-1 RA on mortality, atrial and ventricular arrhythmias, and sudden cardiac death in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Sadawi, Mohammed A., Aslam, Faisal M., Tao, Michael, Alsaiqali, Mahmoud, Almasry, Ibrahim O., Fan, Roger, Rashba, Eric J., Singh, Abhijeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209701/
https://www.ncbi.nlm.nih.gov/pubmed/37252197
http://dx.doi.org/10.1016/j.ijcha.2023.101218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209701/
https://www.ncbi.nlm.nih.gov/pubmed/37252197
http://dx.doi.org/10.1016/j.ijcha.2023.101218

Ejemplares similares